Physician profile
Michael D Andersen
NPI 1871685008
$1,102.42
in general payments reported to CMS, 2019-2025
18 companies · $86.88 in 2025
The $86.88 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.90 · 2020: $151 · 2021: $206 · 2022: $127 · 2023: $429 · 2024: $75.97 · 2025: $86.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $344.25 | 2020-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $138.85 | 2020-2024 | Slynd |
| Alexion Pharmaceuticals, INC. | $126.79 | 2023 | |
| Becton, Dickinson and Company | $72.69 | 2023-2024 | Bd Onclarity |
| Aspira Women'S Health INC | $59.36 | 2021 | |
| Avion Pharmaceuticals | $56.88 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.46 | 2020-2022 | |
| Hologic Sales and Service, LLC | $45.86 | 2022-2025 | Aptima |
| Evofem Biosciences, INC. | $35.53 | 2021 | |
| Pfizer INC. | $29.94 | 2021 | |
| Daiichi Sankyo INC. | $25.83 | 2023 | Injectafer |
| Smith+Nephew, INC. | $22.19 | 2025 | Stravix Pl |
| Biogen, INC. | $20.44 | 2025 | Zurzuvae |
| Millicent US INC | $18.52 | 2025 | Femlyv |
| Therapeuticsmd, INC. | $16.32 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $15.61 | 2024 | Myfembree |
| Ethicon US, LLC | $13.96 | 2019 | |
| Allergan, INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.